Morgan Stanley’s Sonoma Pharmaceuticals SNOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11 Hold
4
﹤0.01% 8026
2025
Q1
$9 Hold
4
﹤0.01% 8015
2024
Q4
$11 Hold
4
﹤0.01% 7908
2024
Q3
$12 Hold
4
﹤0.01% 7857
2024
Q2
$18 Hold
4
﹤0.01% 7746
2024
Q1
$14 Sell
4
-5
-56% -$18 ﹤0.01% 7748
2023
Q4
$32 Buy
9
+5
+125% +$18 ﹤0.01% 7729
2023
Q3
$66 Hold
4
﹤0.01% 7473
2023
Q2
$92 Hold
4
﹤0.01% 7504
2023
Q1
$84 Hold
4
﹤0.01% 7583
2022
Q4
$96 Hold
4
﹤0.01% 7702
2022
Q3
$0 Hold
4
﹤0.01% 7856
2022
Q2
$0 Sell
4
-1
-20% ﹤0.01% 7953
2022
Q1
$0 Sell
5
-122
-96% ﹤0.01% 8102
2021
Q4
$11K Buy
127
+122
+2,440% +$10.6K ﹤0.01% 7447
2021
Q3
$0 Sell
5
-4
-44% ﹤0.01% 8015
2021
Q2
$1K Hold
9
﹤0.01% 7629
2021
Q1
$1K Hold
9
﹤0.01% 7379
2020
Q4
$1K Sell
9
-130
-94% -$14.4K ﹤0.01% 6968
2020
Q3
$23K Buy
139
+126
+969% +$20.8K ﹤0.01% 6012
2020
Q2
$2K Hold
13
﹤0.01% 6463
2020
Q1
$1K Hold
13
﹤0.01% 6485
2019
Q4
$1K Hold
13
﹤0.01% 6586
2019
Q3
$1K Hold
13
﹤0.01% 6571
2019
Q2
$2K Hold
13
﹤0.01% 6473
2019
Q1
$2K Hold
13
﹤0.01% 6467
2018
Q4
$2K Sell
13
-5
-28% -$769 ﹤0.01% 6435
2018
Q3
$5K Hold
18
﹤0.01% 6451
2018
Q2
$8K Hold
18
﹤0.01% 6355
2018
Q1
$12K Hold
18
﹤0.01% 6232
2017
Q4
$18K Hold
18
﹤0.01% 6106
2017
Q3
$17K Buy
18
+3
+20% +$2.83K ﹤0.01% 6058
2017
Q2
$17K Buy
15
+4
+36% +$4.53K ﹤0.01% 6123
2017
Q1
$14K Buy
11
+3
+38% +$3.82K ﹤0.01% 6170
2016
Q4
$7K Hold
8
﹤0.01% 6232
2016
Q3
$6K Buy
8
+6
+300% +$4.5K ﹤0.01% 6207
2016
Q2
$2K Sell
2
-1
-33% -$1K ﹤0.01% 6371
2016
Q1
$3K Hold
3
﹤0.01% 6363
2015
Q4
$3K Sell
3
-12
-80% -$12K ﹤0.01% 6464
2015
Q3
$17K Sell
15
-28
-65% -$31.7K ﹤0.01% 6099
2015
Q2
$55K Buy
43
+39
+975% +$49.9K ﹤0.01% 5825
2015
Q1
$3K Sell
4
-2
-33% -$1.5K ﹤0.01% 6401
2014
Q4
$9K Buy
6
+2
+50% +$3K ﹤0.01% 6235
2014
Q3
$8K Sell
4
-3
-43% -$6K ﹤0.01% 6245
2014
Q2
$20K Sell
7
-163
-96% -$466K ﹤0.01% 6030
2014
Q1
$578K Buy
170
+72
+73% +$245K ﹤0.01% 4450
2013
Q4
$307K Sell
98
-33
-25% -$103K ﹤0.01% 4801
2013
Q3
$322K Sell
131
-13
-9% -$32K ﹤0.01% 4616
2013
Q2
$334K Buy
+144
New +$334K ﹤0.01% 4535